Doxazosin
Product Images NDC 53808-0364

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 53808-0364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 4mg (Doxazosin 4mg(apotex))

Label for Doxazosin Mesylate 4 mg tablets, prescription only, quantity 30. The package is from State of Florida DOH Central Pharmacy, located in Tallahassee, FL. The label includes a lot number, expiration date, and a UPC barcode.*

FDA Label Image

Chemical Structure (Doxazosin Image01)

Chemical structure of Doxazosin mesylate, as shown in the image. The diagram includes molecular components illustrating Doxazosin combined with a methanesulfonic acid (mesylate) group.*

FDA Label Image

Table 1 (Doxazosin Image02)

The image shows a detailed table and accompanying bar graph summarizing the clinical study results on symptom score and maximum urinary flow rate for Doxazosin versus placebo. The table presents mean baseline and change values across three studies with different dosing regimens. The bar graph visually compares the maximum flow rate changes for placebo, 4 mg, and 8 mg doses in study 2, highlighting significant improvements with Doxazosin 4 mg and 8 mg doses.*

FDA Label Image

Figure 1–study 1 (Doxazosin Image03)

Two line graphs from a study illustrating the effects of Doxazosin versus placebo over 14 weeks. The first graph shows the mean change in total symptom score from baseline, where Doxazosin demonstrates a greater reduction compared to placebo. The second graph depicts the mean increase in maximum urinary flow rate from baseline, with Doxazosin showing a higher increase than placebo. Both graphs include data points with error bars and sample sizes of approximately 47-50 subjects per group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.